Hyperfiltration and renal disease in glycogen storage disease, type I
- PMID: 2671467
- DOI: 10.1038/ki.1989.133
Hyperfiltration and renal disease in glycogen storage disease, type I
Abstract
A prospective study of 14 patients (ages 6 months to 33 years) with glycogen storage disease, Type I (GSD-I) was carried out in order to define the character and frequency of renal dysfunction. A marked increase in the glomerular filtration rate (GFR) was documented in virtually all subjects, with the mean GFR raised by approximately 50%, to the range of 170 ml/min/1.73 m2. While this constituted the only renal abnormality found in the younger patients, a significant increase in urinary albumin excretion was seen in three teen-aged individuals; three patients over 20 years of age exhibited frank proteinuria (2 to 8 g/day). Renal biopsy on two of the proteinuric subjects revealed focal and global glomerulosclerosis and interstitial fibrosis. Evaluation of factors known to cause an increase in GFR did not define the precise etiology for its elevation in GSD-I. These studies suggest that: (1) glomerular damage and chronic renal disease are common in older patients with GSD-I; (2) the renal injury appears to be specifically related to GSD-I and is not secondary to the treatment of the disease; and (3) the natural history of the renal lesion in GSD-I may be analogous to that seen in insulin-dependent diabetes, with a "silent" period where hyperfiltration is the only demonstrable renal abnormality, followed by evidence of increasing glomerular damage progressing from microalbuminuria to frank proteinuria.
Similar articles
-
Glomerular and tubular function in glycogen storage disease.Pediatr Nephrol. 1995 Dec;9(6):705-10. doi: 10.1007/BF00868717. Pediatr Nephrol. 1995. PMID: 8747109 Clinical Trial.
-
Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.Pediatr Nephrol. 1991 Jan;5(1):71-6. doi: 10.1007/BF00852851. Pediatr Nephrol. 1991. PMID: 2025544 Review.
-
Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study.Clin Endocrinol (Oxf). 2005 Jul;63(1):19-25. doi: 10.1111/j.1365-2265.2005.02292.x. Clin Endocrinol (Oxf). 2005. PMID: 15963056
-
Renal function and kidney size in glycogen storage disease type I.Pediatr Nephrol. 1992 May;6(3):236-8. doi: 10.1007/BF00878355. Pediatr Nephrol. 1992. PMID: 1616830
-
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Adv Exp Med Biol. 2017. PMID: 27873229 Review.
Cited by
-
In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.J Inherit Metab Dis. 2012 Jul;35(4):671-8. doi: 10.1007/s10545-012-9454-5. Epub 2012 Feb 7. J Inherit Metab Dis. 2012. PMID: 22310927
-
Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome.Pediatr Nephrol. 1995 Jun;9(3):287-91. doi: 10.1007/BF02254185. Pediatr Nephrol. 1995. PMID: 7632512
-
Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia.Pharmacoecon Open. 2023 Jul;7(4):627-638. doi: 10.1007/s41669-023-00397-z. Epub 2023 Apr 11. Pharmacoecon Open. 2023. PMID: 37039966 Free PMC article.
-
Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.Clin J Am Soc Nephrol. 2009 Nov;4(11):1741-6. doi: 10.2215/CJN.00050109. Epub 2009 Oct 1. Clin J Am Soc Nephrol. 2009. PMID: 19808227 Free PMC article.
-
Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?Pediatr Nephrol. 2020 Jan;35(1):9-16. doi: 10.1007/s00467-018-4161-6. Epub 2018 Dec 27. Pediatr Nephrol. 2020. PMID: 30591974 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical